You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TPO-RA

Showing 1 - 25 of 1,632
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

Not yet recruiting
  • Tumor Therapy-related Thrombocytopenia
  • TPO-RA (Herombopag)
  • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
  • (no location specified)
Apr 27, 2022

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

Unknown status
  • Persistent or Chronic ITP
  • Tpo-RA discontinuation
  • Creteil, France
    Henri-Mondor Hospital
Feb 17, 2020

Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • CM313 Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023

Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Antiphospholipid Syndrome
  • Thrombocytopenia
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • eltrombopag and romiplastim
  • (no location specified)
Nov 16, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)

Not yet recruiting
  • Primary Immune Thrombocytopenia
  • 2.5mg/d Hetrombopag
  • (no location specified)
Mar 28, 2022

ITP Trial in Denmark, France, Norway (Daratumumab Injection)

Recruiting
  • ITP
  • Daratumumab Injection
  • Odense, Denmark
  • +5 more
Dec 9, 2021

Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Eltrombopag (Revolade®)
  • standard therapy (without eltrombopag): HD-DXM
  • Aarau, Switzerland
  • +5 more
Sep 5, 2022

Thrombocytopenia Trial in Rochester (Avatrombopag)

Recruiting
  • Thrombocytopenia
  • Rochester, New York
    University of Rochester Medical Center
Jun 9, 2022

Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

Not yet recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
May 26, 2022

Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Completed
  • Wiskott-Aldrich Syndrome
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Dec 24, 2020

Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

Thrombocytopenia Trial (Hetrombopag)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Sep 7, 2023

Evan Syndrome, Treatment Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Evan Syndrome
  • Treatment
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 25, 2023

Immune Thrombocytopenia Trial (Daratumumab Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Daratumumab Injection
  • (no location specified)
Sep 28, 2022

Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)

Enrolling by invitation
  • Lupus Erythematosus, Systemic
  • +3 more
  • rapid GCs taper
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Aug 16, 2022